Novartis AG (NVS)
154.87
+1.43
(+0.93%)
USD |
NYSE |
Mar 16, 16:00
154.87
0.00 (0.00%)
After-Hours: 20:00
Novartis Market Cap : 295.52B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 328.27B |
| Amgen, Inc. | 197.46B |
| AstraZeneca PLC | 297.86B |
| Gilead Sciences, Inc. | 180.29B |
| GSK Plc | 107.73B |
Market Cap Related Metrics
| PE Ratio | 21.55 |
| PS Ratio | 5.524 |
| PEG Ratio | 0.9558 |
| Price to Book Value | 6.406 |
| Price to Free Cash Flow | 19.73 |
| Price | 154.87 |
| Earnings Yield | 4.64% |
| PEGY Ratio | 0.8407 |
| Operating PE Ratio | 17.73 |
| Normalized PE Ratio | 20.49 |